ETHIQA XR

LIVE

Serial Number

87703098

Owner

FIDELIS PHARMACEUTICALS LLC

Attorney

Frederic M. Wilf

First Use Date

Aug 6, 2020

Filing Date

Nov 30, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

ETHIQA XR Trademark

Serial Number: 87703098 • Registration: 6158526

ETHIQA XR is a trademark filed by FIDELIS PHARMACEUTICALS LLC on November 30, 2017. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

FIDELIS PHARMACEUTICALS LLC (3 trademarks)

Suite B113
North Brunswick, NJ 08902

Entity Type: 16

FIDELIS ANIMAL HEALTH, INC. (4 trademarks)

675 HIGHWAY ONE
NORTH BRUNSWICK, NJ 08902

Entity Type: 03

FIDELIS PHARMACEUTICALS, INC. (3 trademarks)

675 US HIGHWAY ONE, SUITE B113
NORTH BRUNSWICK, NJ 08902

Entity Type: 03

Legal Representation

Attorney of Record

Frederic M. Wilf

230 trademarks filed View all →

Correspondence Address

Frederic M. Wilf Wilftek LLC

30 Ardmore Ave #465

Ardmore, PA 19103

United States

Trademark Details

Filing Date

November 30, 2017

Registration Date

September 22, 2020

First Use Anywhere

August 6, 2020

First Use in Commerce

August 6, 2020

Published for Opposition

September 18, 2018

Goods & Services

Pharmaceutical preparations, namely, buprenorphine extended release injectable suspension to provide analgesia for laboratory animals

Filing History

TEAS SECTION 8 & 15 RECEIVED

Apr 6, 2026 E815

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Sep 22, 2025 REM1

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

Jun 22, 2022 ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

May 19, 2022 ASGN

REGISTERED-PRINCIPAL REGISTER

Sep 22, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 21, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 20, 2020 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Aug 19, 2020 SUPC

USE AMENDMENT FILED

Aug 17, 2020 IUAF

TEAS STATEMENT OF USE RECEIVED

Aug 17, 2020 EISU

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Jul 7, 2020 CHAN

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Jul 7, 2020 TCCA

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Jul 7, 2020 COAR

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Apr 4, 2020 EXRA

SOU EXTENSION 3 GRANTED

Apr 2, 2020 EX3G

SOU EXTENSION 3 FILED

Apr 2, 2020 EXT3

SOU TEAS EXTENSION RECEIVED

Apr 2, 2020 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 2, 2019 EXRA

SOU EXTENSION 2 GRANTED

Oct 31, 2019 EX2G

SOU EXTENSION 2 FILED

Oct 31, 2019 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 31, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jun 18, 2019 EXRA

SOU EXTENSION 1 GRANTED

Jun 17, 2019 EX1G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Jun 17, 2019 AITU

NOTICE OF REVIVAL - E-MAILED

May 14, 2019 NREV

SOU EXTENSION RECEIVED WITH TEAS PETITION

May 14, 2019 TPEX

PETITION TO REVIVE-GRANTED

May 14, 2019 PETG

TEAS PETITION TO REVIVE RECEIVED

May 14, 2019 PROA

SOU EXTENSION 1 FILED

May 13, 2019 EXT1

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Nov 28, 2018 CHAN

TEAS CHANGE OF OWNER ADDRESS RECEIVED

Nov 28, 2018 COAR

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Nov 28, 2018 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Nov 28, 2018 REAP

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Nov 13, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 18, 2018 NPUB

PUBLISHED FOR OPPOSITION

Sep 18, 2018 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 29, 2018 NONP

ASSIGNED TO LIE

Aug 16, 2018 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 4, 2018 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 4, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 4, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 4, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

May 7, 2018 GNRN

NON-FINAL ACTION E-MAILED

May 7, 2018 GNRT

NON-FINAL ACTION WRITTEN

May 7, 2018 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 13, 2018 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 13, 2018 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 13, 2018 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 14, 2018 GNRN

NON-FINAL ACTION E-MAILED

Mar 14, 2018 GNRT

NON-FINAL ACTION WRITTEN

Mar 14, 2018 CNRT

ASSIGNED TO EXAMINER

Mar 13, 2018 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 11, 2017 NWOS

NEW APPLICATION ENTERED

Dec 4, 2017 NWAP

Related Trademarks

More from this Owner

FIDELIS

ETHIQA XR (BUPRENORPHINE EXTENDED-RELEASE INJECTABLE SUSPENSION) 1.3 MG/ML

More in Same Class

TFS

SMAKE-UP

AMAPUR

HEALTHY HEIGHT

ADVANCED LIFE SCIENCE

STAY HEALTHY, NATURALLY